Psychosis Relapse Common During Assured Antipsychotic Treatment
Researchers conducted a systematic review and meta-analysis to assess the incidence and predictors of psychosis relapse in individuals receiving treatment with antipsychotic agents.
Schizophrenia & Psychoses
Schizophrenia Practice Guidelines Mostly Recommend Long-Acting Injectable Antipsychotics During First Episode
Recommendations for pharmacotherapy with antipsychotics as both acute and maintenance treatment of schizophrenia were made following a systematic literature review of current clinical practice guidelines.
Weight Gain During Mental Health Treatment May Negatively Impact Hopefulness, Medication Attitudes, and Depression
Researchers conducted a study to investigate the bidirectional nature of the relationship between obesity and depression.
Extrapyramidal Symptoms in Schizophrenia Associated With Higher Healthcare Costs
Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare resources and costs.
Individuals With the Greatest Risk for Schizophrenia Incur Declining Health After Stressful Life Events
Untreated stress amongst healthcare professionals can lead to a multitude of issues while prolonged stress can contribute to burnout. In order to ensure the safety of both clinicians and patients, effective and feasible interventions are needed for individuals and organizations.
Machine Learning May Improve Diagnostic Accuracy in Schizophrenia, Autism Spectrum Disorder
A recent study aimed to assess the ability of classifiers to identify individuals with schizophrenia, autism spectrum disorder, and typical development based on findings from magnetic resonance imaging.
Olanzapine Plus Samidorphan for Schizophrenia Associated With Less Weight Gain
In a phase 3, double-blind trial, the effect of combined olanzapine and samidorphan treatment compared with treatment with olanzapine alone on the weight profile of patients with schizophrenia was evaluated.
Clozapine Teatment Associated With Increased Risk of COVID-19 Infection
Associations found between clozapine treatment and an increased risk of COVID-19 infection in patients with schizophrenia-spectrum disorders
COVID-19: Clozapine Treatment Increases Risk for Infection
The risk for COVID-19 infection among clozapine-treated patients is elevated, according to researchers.
Long-Acting Injectable Antipsychotics May Delay Time to First Hospitalization in Early-Phase Schizophrenia
Compared with usual treatment, the use of long-acting injectable antipsychotics significantly increased the time to first hospitalization in patients with early-phase schizophrenia.
-
Loading...
-
Loading...
Next post in Schizophrenia and Psychoses
